0
0.5
1
1.5
2+
Mortality
46%
Improvement
Relative Risk
Death/ICU
46%
Case
11%
Antiandrogens Koskinen et al. Prophylaxis
Is prophylaxis with antiandrogens beneficial for COVID-19?
Retrospective 352 patients in Finland
Study underpowered to detect differences
c19early.org
Koskinen et al., Annals of Oncology, Jun 2020
Favors various
Favors control